30.32
price up icon3.06%   0.90
after-market Handel nachbörslich: 28.81 -1.51 -4.98%
loading

Finanzdaten der Immunovant Inc-Aktie (IMVT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
6.20%
8.379
8.933 3.572 4.065 3.48
Operating Expenses
31.40%
80.88
61.55 61.80 78.48 64.26
Benefits Costs and Expenses
38.05%
83.47
60.46 61.78 78.01 63.90
Costs And Expenses
38.05%
83.47
60.46 61.78 78.01 63.90
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
37.78%
-72.50
-52.62 -58.23 -74.41 -60.78
Net Interest Income/Expense
6.20%
8.379
8.933 3.572 4.065 3.48
Interest Income/Expense After Provision For Losses
6.20%
8.379
8.933 3.572 4.065 3.48
Income/Loss From Continuing Operations Before Tax
45.73%
-75.09
-51.53 -58.21 -73.95 -60.42
Income Tax Expense/Benefit
314.81%
0.232
-0.108 0.454 -0.011 -0.991
Income/Loss From Continuing Operations After Tax
46.48%
-75.32
-51.42 -58.66 -73.94 -59.43
Net Income/Loss
46.48%
-75.32
-51.42 -58.66 -73.94 -59.43
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.25%
2.5233
144.52 131.16 130.50 2.41
Diluted Average Shares
98.25%
2.5233
144.52 131.16 130.50 2.41
Basic Earnings Per Share
44.44%
-0.52
-0.36 -0.45 -0.57 -0.45
Diluted Earnings Per Share
44.44%
-0.52
-0.36 -0.45 -0.57 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):